Biomarkers of Immune Injury in Cardiometabolic Disorders
International Journal of Molecular Sciences · 05.11.2026 · 27 (21) · 9913
DOI: 10.3390/ijms27219913 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.11.2026. Verfasst von Letao Zhou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West China Second University Hospital, S…. Hauptthemen laut MEDLINE: Biomarkers, Cardiovascular Diseases, Metabolic Diseases. Die Arbeit nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiometabolic disorders are accompanied by persistent immune activation that links metabolic stress to vascular and organ injury. Conventional inflammatory measures capture part of this process, but they provide limited information about tissue origin, biological mechanism and disease trajectory. This narrative review examines emerging biomarkers across genetic and epigenetic regulation, metabolic and oxidative stress, gut microbial exposure, innate immune activation, adaptive immune remodeling and circulating inflammatory responses. It integrates mechanistic studies with clinical observations to consider how these signals may inform the assessment of cardiometabolic immune injury. Particular attention is given to the distinction between inherited susceptibility and acquired responses, circulating associations and tissue mechanisms, and potentially injurious versus compensatory immune activity. The evidence supports substantial biological connectivity among these domains, while the strength of clinical validation varies widely. Most candidate markers and proposed combinations require standardized measurement, longitudinal assessment and external validation before biomarker-guided prevention can be justified. We propose a mechanism-informed framework for organizing candidate immune-metabolic phenotypes, recognizing reciprocal interactions rather than a universal temporal sequence. Future studies should determine whether these biomarkers improve prediction and clinical decisions beyond established risk factors and whether changes in biomarker profiles correspond to meaningful treatment benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
ORCID-Profile: Letao Zhou, Yifei Li
Zitieren
APA
Zhou, L., & Li, Y. (2026). Biomarkers of Immune Injury in Cardiometabolic Disorders. International Journal of Molecular Sciences, 27(21), 9913. https://doi.org/10.3390/ijms27219913
Vancouver
Zhou L, Li Y. Biomarkers of Immune Injury in Cardiometabolic Disorders. International Journal of Molecular Sciences. 2026;27(21):9913. doi:10.3390/ijms27219913
BibTeX
@article{Zhou2026,
author = {Zhou, Letao and Li, Yifei},
title = {Biomarkers of Immune Injury in Cardiometabolic Disorders},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {21},
pages = {9913},
doi = {10.3390/ijms27219913}
}
EUVIMED